Aziyo Biologics Analysis

AZYODelisted Stock  USD 2.44  0.00  0.00%   
Aziyo Biologics is overvalued with Real Value of 2.05 and Hype Value of 2.44. The main objective of Aziyo Biologics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Aziyo Biologics is worth, separate from its market price. There are two main types of Aziyo Biologics' stock analysis: fundamental analysis and technical analysis.
The Aziyo Biologics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Aziyo Biologics is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Aziyo Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Aziyo Stock Analysis Notes

About 70.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.18. Aziyo Biologics had not issued any dividends in recent years. Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 162 people. For more info on Aziyo Biologics please contact the company at 240 247 1170 or go to https://www.aziyo.com.

Aziyo Biologics Investment Alerts

Aziyo Biologics is not yet fully synchronised with the market data
Aziyo Biologics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 49.19 M. Net Loss for the year was (32.9 M) with profit before overhead, payroll, taxes, and interest of 19.22 M.
Aziyo Biologics currently holds about 16.49 M in cash with (21.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21.
Roughly 70.0% of the company shares are held by institutions such as insurance companies

Aziyo Biologics Upcoming and Recent Events

Earnings reports are used by Aziyo Biologics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
13th of November 2023
Upcoming Quarterly Report
View
27th of March 2024
Next Financial Report
View
30th of September 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of June 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Aziyo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.72 M.

Aziyo Profitablity

The company has Profit Margin (PM) of (0.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.5) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.5.

Aziyo Biologics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aziyo Biologics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aziyo Biologics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aziyo Biologics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aziyo Biologics Outstanding Bonds

Aziyo Biologics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aziyo Biologics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aziyo bonds can be classified according to their maturity, which is the date when Aziyo Biologics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Aziyo Biologics Predictive Daily Indicators

Aziyo Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aziyo Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Aziyo Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aziyo Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aziyo shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Aziyo Biologics. By using and applying Aziyo Stock analysis, traders can create a robust methodology for identifying Aziyo entry and exit points for their positions.
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 162 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aziyo Biologics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities